FEB 26, 2020 3:41 PM PST

Why is heart disease the world's leading cause of death?

WRITTEN BY: Annie Lennon

Heart diseases, also known as cardiovascular diseases (CVDs) are the number 1 cause of death around the world. In 2016 alone, 17.9 million people died from CVDs, accounting for 31% of deaths globally, with 85% of these having been due to a heart attack or stroke. But why is this? Why is heart disease the world’s leading cause of death?

Just 120 years ago, at the turn of the last century, CVDs were considered a relatively minor disease. So what has happened in the last 120 years to make it the world’s biggest killer? As it turns out, a lot of this may be due to improved public health measures and general medical care. For example, back then, antibiotics and vaccines as well as general knowledge on preventative care were not as widespread as they are today, meaning that pneumonia and flu could take centre stage as a leading cause of death, followed by tuberculosis and digestive disease. 

Thus, in many ways, the explosion of CVD deaths per year comes as other killer diseases and conditions are just better avoided. However, how does it play out on a more macro level? When zooming out, it seems that CVD mortality rates correlate with economic, social and demographic forces. 

An example of this is how during times of pestilence and famine, CVD tends to count for just 5-10% of mortality rates, with deadly forms of the condition being attributed to infection and malnutrition. Sub-Saharan Africa seems to be at this stage currently, wherein deaths from communicable diseases still far outpace those from more chronic diseases like CVD. 

However, in times of increasing wealth and higher food availability, the causes behind CVD change, and its mortality rate tends to skyrocket. This comes as increased wealth allows for better nutrition and thus reduced infant mortality rates. This, coupled with general improvements in public health, then causes deaths from infectious diseases to decline, as we can see in some Caribbean countries as well as regions in Latin America, India and China. 

Then, as improvements in economic circumstances combine with urbanization and changes the nature of work-related activities, dramatic changes in diet, activity levels and behaviors (such as smoking) start to proliferate more rapidly. Where degenerative diseases start to take centre-stage, cheaper, more plentiful and more nutritionally-dense foods (particularly in sugar and fat) increase caloric intake, while further mechanization means that people spend fewer calories in exercise. This then leads to higher body mass indexes, higher plasma lipid levels and blood pressure- key prerequisites for CVD. Such lifestyle changes thus mean that CVD becomes responsible for 35%-65% of all deaths, something that is currently visible in emerging market economies such as those in the former Soviet Union and areas of the Middle East.

The final phase of the transition however, which sees chronic diseases such as CVD and cancer as the main causes of death also coincides with technological advances to treat the conditions, such as coronary care units and thrombolytic therapy, and preventative measures such as smoking cessation and blood pressure management. Due to these factors, deaths are prevented or belated, meaning that CVD tends to affect older and older individuals while life expectancy creeps upwards and age-adjusted CVD mortality rates decline. This is where countries such as the US and those in Western Europe stand now. 

To conclude, it seems that heart disease is the world’s leading cause of death largely due to improved medicine practices staving off death from other factors like infections, alongside  lifestyle choices that encourage cardiovascular degeneration. Although preventative measures and better healthcare may belate it from taking hold, even in more advanced economies, it still keeps the bottom line in claiming lives, only perhaps increasingly in the guise of  'dying from old age’. 


 

Sources: Medscape, European Society of Cardiology, PMC, WHO and Cleveland Clinic

 

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
AUG 11, 2020
Cardiology
Investigating the Link Between a Kidney Protein and Hypertension
AUG 11, 2020
Investigating the Link Between a Kidney Protein and Hypertension
Hypertension, or high blood pressure, is a common cardiovascular condition with plenty of treatment options and preventi ...
SEP 17, 2020
Cardiology
Can Grape Polyphenol Extracts prevent Cardiotoxicity?
SEP 17, 2020
Can Grape Polyphenol Extracts prevent Cardiotoxicity?
One of the biggest issues with chemotherapy treatments is their inherent toxicities. Most chemotherapy drugs are toxic t ...
SEP 18, 2020
Clinical & Molecular DX
Open Your Heart to the World's Smallest Diagnostic Probe
SEP 18, 2020
Open Your Heart to the World's Smallest Diagnostic Probe
Certain health conditions require doctors to be able to observe tissues and organs in order to tell what’s wrong. ...
SEP 28, 2020
Cardiology
A Single-Cell Atlas Provides New Details on the Heart
SEP 28, 2020
A Single-Cell Atlas Provides New Details on the Heart
For the first time, researchers have gained unprecedented insight into the function of the healthy human heart by creati ...
OCT 15, 2020
Cardiology
Measuring Pulse Transit Time as a Replacement for the Inflatable Cuff
OCT 15, 2020
Measuring Pulse Transit Time as a Replacement for the Inflatable Cuff
Many people deal with one disease or another every day of their life. Most require checking on things like blood sugar f ...
NOV 22, 2020
Genetics & Genomics
Many Kids with Inherited High Cholesterol Don't Get the Treatment They Need
NOV 22, 2020
Many Kids with Inherited High Cholesterol Don't Get the Treatment They Need
Our bodies need cholesterol for certain crucial functions; it's a vital component of cell walls, for example. But there ...
Loading Comments...